39 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
device reporting regulations, we are required to report to the FDA any incident in which information reasonably suggests that our product may have
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
. Under the FDA’s medical device reporting regulations, we are required to report to the FDA any incident in which information reasonably suggests
S-1/A
EX-1.1
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
with the Blue Sky survey; (iv) all fees and expenses in connection with listing the Shares and Warrant Shares on Nasdaq; (v) the filing fees incident … , and the cost of aircraft and other transportation chartered in connection with the road show; and (ix) all other costs and expenses incident
S-1
7k5ue1
13 Dec 23
IPO registration
5:30pm
8-K
EX-10.7
eeo3ai
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.8
f93lnd
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
54fkp4ablz
23 Aug 22
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
4:11pm
8-K
EX-10.1
du1f9zsnvc5
25 Mar 22
Entry into a Material Definitive Agreement
3:00pm
8-K
EX-10.1
7e3gudyew2sxdkmw
23 Sep 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-10.2
wc9wf9s 013oa41y42ue
23 Sep 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-1.1
jgn m5fdvj
28 May 21
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-10.1
fpy5ex nls
28 Dec 20
Entry into a Material Definitive Agreement
2:30pm
8-K
EX-10.2
0trclfsfu7h3lyuqk61
28 Dec 20
Entry into a Material Definitive Agreement
2:30pm